RCE.AX · RECCE PHARMACEUTICALS LTD
Australia · RS rating 16 · As of 2026-10-14
| Price | 0.29 AUD |
|---|---|
| 1-day change | +9.4% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 33 / 18 / 43 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 18 / 15 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +58.9% |
| Market cap (USD) | $62.8M |